JANET DOVE: Open Payments
NPI 1982860664 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$120 in 6 payments from 4 companies in 2025. Trend: 2023 $827 · 2024 $759 · 2025 $120
Food & beverage: $120
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| ACADIA Pharmaceuticals Inc | 2 | $34 |
| MDD US Operations, LLC | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: KESIMPTA, NUPLAZID, Qelbree, AUSTEDO XR.
Industry payments across CA — which companies pay providers there.
